SENDhelp
Life expectancy for people with Down’s syndrome has increased dramatically over the past 80 years, from around 12 years in the 1940s to a median of 58 to 65 years today. This guide explains the factors that affect life expectancy and what has driven the improvement.
Life expectancy for people with Down’s syndrome has increased dramatically over the past eight decades. DSMIG data confirms that median life expectancy in the UK for people with Down’s syndrome is 58 years, a figure that has risen from a mean of just 12 years in the 1940s. Intellectual Disability and Health places the current range at 60 to 65 years, with many people with Down’s syndrome living longer. This improvement reflects advances in cardiac surgery for congenital heart defects, better treatment of respiratory infections, improved management of other associated health conditions and greater inclusion in health services. Despite this progress, life expectancy for people with Down’s syndrome remains lower than for the general population.
SENDhelp places specialist SEN teachers, teaching assistants and support staff in schools and provisions across North London, Bedfordshire, Buckinghamshire and Hertfordshire. If your school needs staff experienced with Down’s syndrome, we can help.
The most significant single factor in the improvement in life expectancy has been cardiac surgery. Approximately 40 to 50 percent of people with Down’s syndrome are born with congenital heart defects, many of which were previously untreatable and fatal in infancy. The development of surgical techniques to correct these defects, now routinely performed in specialist centres, has allowed many children with Down’s syndrome to survive into adulthood. Improvements in antibiotic treatment of respiratory infections, thyroid management and access to general healthcare have also contributed significantly.
Congenital heart defects are the primary cause of early death in Down’s syndrome. The CDC confirms that between 50 and 65 percent of babies born with Down’s syndrome are also born with a congenital heart defect, and AlphaBiolabs confirms that infants with Down’s syndrome who have a congenital heart defect are much less likely to survive past one year without surgical intervention. With appropriate cardiac screening and timely surgical correction, many children with Down’s syndrome who would previously have died in infancy now reach adulthood.
People with Down’s syndrome are more susceptible to respiratory and gastrointestinal infections than the general population, and respiratory infections remain a significant cause of morbidity and premature death. Lower muscle tone affecting the respiratory muscles, structural differences in the airways and immune system differences all contribute to this vulnerability. Good respiratory health management, including vaccination, prompt treatment of infections and monitoring of respiratory function, is important throughout the lifespan.
Adults with Down’s syndrome have a significantly elevated risk of developing Alzheimer’s disease, related to the presence of an extra copy of the gene for amyloid precursor protein on chromosome 21. The Alzheimer’s Society confirms that around one in three people with Down’s syndrome develop Alzheimer’s disease by the age of 60, and this proportion rises with age. The onset of Alzheimer’s disease in people with Down’s syndrome typically occurs at an earlier age than in the general population, often in the 40s or 50s.
AlphaBiolabs notes that low birth weight and birth weight below 3.3 pounds significantly reduce the chance of survival past one month. Ethnicity-related disparities in infant mortality rates have also been documented, with non-Caucasian infants showing higher infant mortality rates for reasons that are not yet fully understood. Access to healthcare, quality of support and the management of co-occurring conditions all influence life expectancy for individuals with Down’s syndrome.
With appropriate healthcare and support, many adults with Down’s syndrome are living healthy and fulfilling lives well into their sixties and beyond. Regular health monitoring, including thyroid function checks, cardiac monitoring, eye and hearing checks and screening for the early signs of dementia, is essential for adults with Down’s syndrome and supports early intervention when problems arise. Healthcare professionals should be familiar with the specific health monitoring needs of adults with Down’s syndrome and provide age-appropriate health checks throughout the lifespan.
For related information see our articles on Down’s Syndrome Health Conditions and Heart Conditions in Down’s Syndrome.
Current estimates place life expectancy for people with Down’s syndrome in the UK at around 58 to 65 years. This represents a dramatic improvement from the 1940s when mean life expectancy was around 12 years. The improvement reflects advances in cardiac surgery, better infection treatment and improved healthcare access. Many people with Down’s syndrome live into their sixties and beyond.
Congenital heart defects are the leading cause of early death in Down’s syndrome, particularly in infancy before surgical correction is possible. In adult life, respiratory infections and, increasingly, Alzheimer’s disease are significant causes of death and morbidity. With appropriate cardiac screening and surgical correction in infancy, many people with Down’s syndrome now live well into adulthood.
Not all people with Down’s syndrome develop Alzheimer’s disease, but the risk is significantly elevated compared to the general population. The Alzheimer’s Society estimates that around one in three people with Down’s syndrome develop Alzheimer’s by age 60, and this proportion increases with age. Research into the link between Down’s syndrome and Alzheimer’s disease is active, and Down’s syndrome registers are contributing to dementia research more broadly.
Visit our Understanding Down’s Syndrome hub for more guides on causes, diagnosis, education, health conditions and independent living.
The information in this article is provided for educational purposes only and is not intended as medical advice. If you have concerns about Down’s syndrome or any health condition, speak to a qualified healthcare professional. SENDhelp Education Limited accepts no responsibility or liability for any loss or damage arising from reliance on this content. Any links to third-party websites are provided for convenience only and do not constitute endorsement of their content.
To stop receiving marketing emails or SMS’s from SENDhelp, kindly complete the form below. We strive to promptly remove your information, aiming to complete the process as soon as we receive your submission.